_id
6911c008ccc777a4e85d6358
Ticker
GRRMY
Name
Gerresheimer AG
Exchange
PINK
Address
Klaus-Bungert-Strasse 4, Düsseldorf, Germany, 40468
Country
USA
Sector
Healthcare
Industry
Medical Instruments & Supplies
Currency
USD
Website
https://www.gerresheimer.com
Description
Gerresheimer AG, together with its subsidiaries, provides medicine packaging, drug delivery devices, and solutions in Germany and internationally. The company operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. It offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and containers, bottles, caps, closures, applicators, and accessories; development, industrialization and contract manufacturing of drug delivery programs; project and quality management; and drug delivery devices, including inhalers, injection/auto injectors, and pen injectors. The company also provides diagnostic and medical devices comprising point-of-care tests, laboratory disposables, chemical and technical bottles, diagnostic and polymer vials, dropper bottles, PET bottles, and medical products comprising lancing devices, infusion sets, and disposable systems. In addition, it offers cosmetic packaging solutions, such as moulded glass flacons and jars; tubular glass ampoules, droppers, samplers and vials; and plastic packaging products, as well as pharmaceutical, laboratory, and regulatory affairs services. The company offers its products to pharmacy chains, supermarkets, and wholesalers. It serves pharma, biotech, medical technology, diagnostics, cosmetics, glass containers, and food and beverage industries. Gerresheimer AG was founded in 1864 and is based in Düsseldorf, Germany.
Last Close
7.7775
Volume
-
Current Price
7.7775
Change
0
Last Updated
2026-01-03T12:57:36.500Z
Image
-
Ipo Date
-
Market Cap
1074539392
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.997
Sentiment Sources
1
Current Quarter
2025-05-31
Revenue
600655000
Cost Of Revenue
442825000
Gross Profit
157830000
Operating Expenses
549987000
Operating Income
50668000
Interest Expense
23577000
Pretax Income
28777000
Net Income
17023000
Eps
0.4928488708743486
Dividends Per Share
-
Shares Outstanding
138160000
Income Tax Expense
-
EBITDA
-
Operating Margin
8.43545795839542
Total Other Income Expense Net
-
Cash
177452000
Short Term Investments
26005000
Receivables
290776000
Inventories
504736000
Total Current Assets
1137549000
Property Plant Equipment
1809786000
Total Assets
4755362000
Payables
314577000
Short Term Debt
-
Long Term Debt
-
Total Liabilities
3289364000
Equity
1440013000
Bs_currency_symbol
EUR
Depreciation
67053000
Change In Working Capital
-15280000
Cash From Operations
62026000
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
-
Net Change In Cash
23371000
Cf_currency_symbol
EUR
PE
38.8875
PB
0.18655029503205875
ROE
1.182142105661546
ROA
0.3579748502847943
FCF
62026000
Fcf Percent
0.10326393686891809
Piotroski FScore
4
Health Score
46
Deep Value Investing Score
6.5
Defensive Investing Score
5.5
Dividend Investing Score
3
Economic Moat Investing Score
5.8
Garp Investing Score
3.5
Growth Investing Score
3.5
Momentum Investing Score
5
Net Net Investing Score
4
Quality Investing Score
4
Value Investing Score
6.5
Quarters > 0 > quarter
2025-05-31
Quarters > 0 > income Statement > revenue
600655000
Quarters > 0 > income Statement > cost Of Revenue
442825000
Quarters > 0 > income Statement > gross Profit
157830000
Quarters > 0 > income Statement > operating Expenses
549987000
Quarters > 0 > income Statement > operating Income
50668000
Quarters > 0 > income Statement > interest Expense
23577000
Quarters > 0 > income Statement > pretax Income
28777000
Quarters > 0 > income Statement > net Income
17023000
Quarters > 0 > income Statement > eps
0.4928488708743486
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
34540000
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
8.43545795839542
Quarters > 0 > income Statement > total Other Income Expense Net
-
Quarters > 0 > income Statement > currency_symbol
EUR
Quarters > 0 > balance Sheet > cash
177452000
Quarters > 0 > balance Sheet > short Term Investments
26005000
Quarters > 0 > balance Sheet > receivables
290776000
Quarters > 0 > balance Sheet > inventories
504736000
Quarters > 0 > balance Sheet > total Current Assets
1137549000
Quarters > 0 > balance Sheet > property Plant Equipment
1809786000
Quarters > 0 > balance Sheet > total Assets
4755362000
Quarters > 0 > balance Sheet > payables
314577000
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
3289364000
Quarters > 0 > balance Sheet > equity
1440013000
Quarters > 0 > balance Sheet > currency_symbol
EUR
Quarters > 0 > cash Flow > net Income
17023000
Quarters > 0 > cash Flow > depreciation
67053000
Quarters > 0 > cash Flow > change In Working Capital
-15280000
Quarters > 0 > cash Flow > cash From Operations
62026000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-
Quarters > 0 > cash Flow > net Change In Cash
23371000
Quarters > 0 > cash Flow > currency_symbol
EUR
Quarters > 0 > ratios > PE
0.4928488708743486
Quarters > 0 > ratios > PB
0.18655029503205875
Quarters > 0 > ratios > ROE
1.182142105661546
Quarters > 0 > ratios > ROA
0.3579748502847943
Quarters > 0 > ratios > FCF
62026000
Quarters > 0 > ratios > Piotroski FScore
4
Quarters > 0 > ratios > fcf Percent
0.10326393686891809
Quarters > 0 > health Score
46
Quarters > 1 > quarter
2025-02-28
Quarters > 1 > income Statement > revenue
520054000
Quarters > 1 > income Statement > cost Of Revenue
393304000
Quarters > 1 > income Statement > gross Profit
126750000
Quarters > 1 > income Statement > operating Expenses
504936000
Quarters > 1 > income Statement > operating Income
15118000
Quarters > 1 > income Statement > interest Expense
42532000
Quarters > 1 > income Statement > pretax Income
-25319000
Quarters > 1 > income Statement > net Income
-18013000
Quarters > 1 > income Statement > eps
-0.5215112912565142
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
34540000
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
2.9070058109350185
Quarters > 1 > income Statement > total Other Income Expense Net
-
Quarters > 1 > income Statement > currency_symbol
EUR
Quarters > 1 > balance Sheet > cash
150786000
Quarters > 1 > balance Sheet > short Term Investments
33068000
Quarters > 1 > balance Sheet > receivables
322218000
Quarters > 1 > balance Sheet > inventories
516648000
Quarters > 1 > balance Sheet > total Current Assets
1160414000
Quarters > 1 > balance Sheet > property Plant Equipment
1826786000
Quarters > 1 > balance Sheet > total Assets
4840721000
Quarters > 1 > balance Sheet > payables
350266000
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
3300754000
Quarters > 1 > balance Sheet > equity
1512632000
Quarters > 1 > balance Sheet > currency_symbol
EUR
Quarters > 1 > cash Flow > net Income
-18013000
Quarters > 1 > cash Flow > depreciation
67188000
Quarters > 1 > cash Flow > change In Working Capital
-62513000
Quarters > 1 > cash Flow > cash From Operations
-27784000
Quarters > 1 > cash Flow > capital Expenditures
480490000
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
-
Quarters > 1 > cash Flow > net Change In Cash
-48365000
Quarters > 1 > cash Flow > currency_symbol
EUR
Quarters > 1 > ratios > PE
-0.5215112912565142
Quarters > 1 > ratios > PB
0.1775943190412473
Quarters > 1 > ratios > ROE
-1.190838221061038
Quarters > 1 > ratios > ROA
-0.3721139888045603
Quarters > 1 > ratios > FCF
-508274000
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-0.9773485061166725
Quarters > 1 > health Score
19
Quarters > 2 > quarter
2024-11-30
Quarters > 2 > income Statement > revenue
568873000
Quarters > 2 > income Statement > cost Of Revenue
387193000
Quarters > 2 > income Statement > gross Profit
181680000
Quarters > 2 > income Statement > operating Expenses
471184000
Quarters > 2 > income Statement > operating Income
97689000
Quarters > 2 > income Statement > interest Expense
17465000
Quarters > 2 > income Statement > pretax Income
47581000
Quarters > 2 > income Statement > net Income
37041000
Quarters > 2 > income Statement > eps
1.072408801389693
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
34540000
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
17.172374150293653
Quarters > 2 > income Statement > total Other Income Expense Net
-
Quarters > 2 > income Statement > currency_symbol
EUR
Quarters > 2 > balance Sheet > cash
186378000
Quarters > 2 > balance Sheet > short Term Investments
26681000
Quarters > 2 > balance Sheet > receivables
310641000
Quarters > 2 > balance Sheet > inventories
349744000
Quarters > 2 > balance Sheet > total Current Assets
992301000
Quarters > 2 > balance Sheet > property Plant Equipment
1506265000
Quarters > 2 > balance Sheet > total Assets
3809164000
Quarters > 2 > balance Sheet > payables
354582000
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
870807000
Quarters > 2 > balance Sheet > total Liabilities
2270023000
Quarters > 2 > balance Sheet > equity
1511562000
Quarters > 2 > balance Sheet > currency_symbol
EUR
Quarters > 2 > cash Flow > net Income
37041000
Quarters > 2 > cash Flow > depreciation
52015000
Quarters > 2 > cash Flow > change In Working Capital
68785000
Quarters > 2 > cash Flow > cash From Operations
133826000
Quarters > 2 > cash Flow > capital Expenditures
89919000
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
-
Quarters > 2 > cash Flow > net Change In Cash
81875000
Quarters > 2 > cash Flow > currency_symbol
EUR
Quarters > 2 > ratios > PE
1.072408801389693
Quarters > 2 > ratios > PB
0.17772003397809683
Quarters > 2 > ratios > ROE
2.4505114576841702
Quarters > 2 > ratios > ROA
0.9724180948890623
Quarters > 2 > ratios > FCF
43907000
Quarters > 2 > ratios > Piotroski FScore
4
Quarters > 2 > ratios > fcf Percent
0.07718242911862577
Quarters > 2 > health Score
49
Quarters > 3 > quarter
2024-08-31
Quarters > 3 > income Statement > revenue
498514000
Quarters > 3 > income Statement > cost Of Revenue
350677000
Quarters > 3 > income Statement > gross Profit
147837000
Quarters > 3 > income Statement > operating Expenses
450131000
Quarters > 3 > income Statement > operating Income
48383000
Quarters > 3 > income Statement > interest Expense
15458000
Quarters > 3 > income Statement > pretax Income
35152000
Quarters > 3 > income Statement > net Income
27209000
Quarters > 3 > income Statement > eps
0.7877533294730747
Quarters > 3 > income Statement > dividends Per Share
43174000
Quarters > 3 > income Statement > shares Outstanding
34540000
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
9.70544458129561
Quarters > 3 > income Statement > total Other Income Expense Net
-
Quarters > 3 > income Statement > currency_symbol
EUR
Quarters > 3 > balance Sheet > cash
109450000
Quarters > 3 > balance Sheet > short Term Investments
21362000
Quarters > 3 > balance Sheet > receivables
273368000
Quarters > 3 > balance Sheet > inventories
371864000
Quarters > 3 > balance Sheet > total Current Assets
876632000
Quarters > 3 > balance Sheet > property Plant Equipment
1389890000
Quarters > 3 > balance Sheet > total Assets
3563247000
Quarters > 3 > balance Sheet > payables
302700000
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
2105038000
Quarters > 3 > balance Sheet > equity
1432260000
Quarters > 3 > balance Sheet > currency_symbol
EUR
Quarters > 3 > cash Flow > net Income
27700000
Quarters > 3 > cash Flow > depreciation
50416000
Quarters > 3 > cash Flow > change In Working Capital
-3640000
Quarters > 3 > cash Flow > cash From Operations
71264000
Quarters > 3 > cash Flow > capital Expenditures
82084000
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
-
Quarters > 3 > cash Flow > net Change In Cash
24719000
Quarters > 3 > cash Flow > currency_symbol
EUR
Quarters > 3 > ratios > PE
0.7877533294730747
Quarters > 3 > ratios > PB
0.18756011478362866
Quarters > 3 > ratios > ROE
1.8997249102816527
Quarters > 3 > ratios > ROA
0.763601288375462
Quarters > 3 > ratios > FCF
-10820000
Quarters > 3 > ratios > Piotroski FScore
4
Quarters > 3 > ratios > fcf Percent
-0.02170450579121148
Quarters > 3 > health Score
43
Annuals > 0 > quarter
2024-11-30
Annuals > 0 > income Statement > revenue
2035903000
Annuals > 0 > income Statement > cost Of Revenue
1428138000
Annuals > 0 > income Statement > gross Profit
607765000
Annuals > 0 > income Statement > operating Expenses
1802308000
Annuals > 0 > income Statement > operating Income
233595000
Annuals > 0 > income Statement > interest Expense
60625000
Annuals > 0 > income Statement > pretax Income
146813000
Annuals > 0 > income Statement > net Income
109720000
Annuals > 0 > income Statement > eps
3.176606832657788
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
34540000
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
11.473778465869936
Annuals > 0 > income Statement > total Other Income Expense Net
-
Annuals > 0 > income Statement > currency_symbol
EUR
Annuals > 0 > balance Sheet > cash
186378000
Annuals > 0 > balance Sheet > short Term Investments
26681000
Annuals > 0 > balance Sheet > receivables
310641000
Annuals > 0 > balance Sheet > inventories
349744000
Annuals > 0 > balance Sheet > total Current Assets
992301000
Annuals > 0 > balance Sheet > property Plant Equipment
1506265000
Annuals > 0 > balance Sheet > total Assets
3809164000
Annuals > 0 > balance Sheet > payables
354582000
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
870807000
Annuals > 0 > balance Sheet > total Liabilities
2270023000
Annuals > 0 > balance Sheet > equity
1511562000
Annuals > 0 > balance Sheet > currency_symbol
EUR
Annuals > 0 > cash Flow > net Income
109720000
Annuals > 0 > cash Flow > depreciation
198532000
Annuals > 0 > cash Flow > change In Working Capital
-8770000
Annuals > 0 > cash Flow > cash From Operations
240332000
Annuals > 0 > cash Flow > capital Expenditures
369846000
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
-
Annuals > 0 > cash Flow > net Change In Cash
63015000
Annuals > 0 > cash Flow > currency_symbol
EUR
Annuals > 0 > ratios > PE
3.176606832657788
Annuals > 0 > ratios > PB
0.17772003397809683
Annuals > 0 > ratios > ROE
7.2587164800385295
Annuals > 0 > ratios > ROA
2.8804220558631766
Annuals > 0 > ratios > FCF
-129514000
Annuals > 0 > ratios > Piotroski FScore
4
Annuals > 0 > ratios > fcf Percent
-0.06361501505720066
Annuals > 0 > health Score
49
Annuals > 1 > quarter
2023-11-30
Annuals > 1 > income Statement > revenue
1990486000
Annuals > 1 > income Statement > cost Of Revenue
1393172000
Annuals > 1 > income Statement > gross Profit
597314000
Annuals > 1 > income Statement > operating Expenses
1761017000
Annuals > 1 > income Statement > operating Income
229469000
Annuals > 1 > income Statement > interest Expense
50435000
Annuals > 1 > income Statement > pretax Income
167429000
Annuals > 1 > income Statement > net Income
116126000
Annuals > 1 > income Statement > eps
3.3620729588882456
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
34540000
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
11.528290075891015
Annuals > 1 > income Statement > total Other Income Expense Net
-
Annuals > 1 > income Statement > currency_symbol
EUR
Annuals > 1 > balance Sheet > cash
122339000
Annuals > 1 > balance Sheet > short Term Investments
14412000
Annuals > 1 > balance Sheet > receivables
278383000
Annuals > 1 > balance Sheet > inventories
323343000
Annuals > 1 > balance Sheet > total Current Assets
849574000
Annuals > 1 > balance Sheet > property Plant Equipment
1268540000
Annuals > 1 > balance Sheet > total Assets
3429139000
Annuals > 1 > balance Sheet > payables
387283000
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
612816000
Annuals > 1 > balance Sheet > total Liabilities
1956772000
Annuals > 1 > balance Sheet > equity
1445660000
Annuals > 1 > balance Sheet > currency_symbol
EUR
Annuals > 1 > cash Flow > net Income
116126000
Annuals > 1 > cash Flow > depreciation
186026000
Annuals > 1 > cash Flow > change In Working Capital
31776000
Annuals > 1 > cash Flow > cash From Operations
294337000
Annuals > 1 > cash Flow > capital Expenditures
328037000
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
-
Annuals > 1 > cash Flow > net Change In Cash
27253000
Annuals > 1 > cash Flow > currency_symbol
EUR
Annuals > 1 > ratios > PE
3.3620729588882456
Annuals > 1 > ratios > PB
0.18582159705601592
Annuals > 1 > ratios > ROE
8.032732454380698
Annuals > 1 > ratios > ROA
3.3864477351311804
Annuals > 1 > ratios > FCF
-33700000
Annuals > 1 > ratios > Piotroski FScore
4
Annuals > 1 > ratios > fcf Percent
-0.016930538571986942
Annuals > 1 > health Score
50
Annuals > 2 > quarter
2022-11-30
Annuals > 2 > income Statement > revenue
1817094000
Annuals > 2 > income Statement > cost Of Revenue
1270282000
Annuals > 2 > income Statement > gross Profit
546812000
Annuals > 2 > income Statement > operating Expenses
1597795000
Annuals > 2 > income Statement > operating Income
219299000
Annuals > 2 > income Statement > interest Expense
27955000
Annuals > 2 > income Statement > pretax Income
140811000
Annuals > 2 > income Statement > net Income
96120000
Annuals > 2 > income Statement > eps
3.0611464968152866
Annuals > 2 > income Statement > dividends Per Share
39250000
Annuals > 2 > income Statement > shares Outstanding
31400000
Annuals > 2 > income Statement > income Tax Expense
38620000
Annuals > 2 > income Statement > EBITDA
340321000
Annuals > 2 > income Statement > operating Margin
12.068665682677947
Annuals > 2 > income Statement > total Other Income Expense Net
-
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
112789000
Annuals > 2 > balance Sheet > short Term Investments
12045000
Annuals > 2 > balance Sheet > receivables
269835000
Annuals > 2 > balance Sheet > inventories
310714000
Annuals > 2 > balance Sheet > total Current Assets
810137000
Annuals > 2 > balance Sheet > property Plant Equipment
1060915000
Annuals > 2 > balance Sheet > total Assets
3354293000
Annuals > 2 > balance Sheet > payables
356789000
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
638584000
Annuals > 2 > balance Sheet > total Liabilities
2084918000
Annuals > 2 > balance Sheet > equity
1242919000
Annuals > 2 > balance Sheet > currency_symbol
EUR
Annuals > 2 > cash Flow > net Income
96120000
Annuals > 2 > cash Flow > depreciation
169242000
Annuals > 2 > cash Flow > change In Working Capital
-61617000
Annuals > 2 > cash Flow > cash From Operations
221941000
Annuals > 2 > cash Flow > capital Expenditures
256526000
Annuals > 2 > cash Flow > cash From Investing
-256181000
Annuals > 2 > cash Flow > cash From Financing
44239000
Annuals > 2 > cash Flow > net Change In Cash
14547000
Annuals > 2 > cash Flow > currency_symbol
EUR
Annuals > 2 > ratios > PE
3.0611464968152866
Annuals > 2 > ratios > PB
0.1964838416662711
Annuals > 2 > ratios > ROE
7.7334082108327244
Annuals > 2 > ratios > ROA
2.8655815100231257
Annuals > 2 > ratios > FCF
-34585000
Annuals > 2 > ratios > Piotroski FScore
3
Annuals > 2 > ratios > fcf Percent
-0.019033137526181916
Annuals > 2 > health Score
48
Annuals > 3 > quarter
2021-11-30
Annuals > 3 > income Statement > revenue
1498007000
Annuals > 3 > income Statement > cost Of Revenue
1055779000
Annuals > 3 > income Statement > gross Profit
442228000
Annuals > 3 > income Statement > operating Expenses
1319175000
Annuals > 3 > income Statement > operating Income
178832000
Annuals > 3 > income Statement > interest Expense
20702000
Annuals > 3 > income Statement > pretax Income
127865000
Annuals > 3 > income Statement > net Income
83788000
Annuals > 3 > income Statement > eps
2.668407643312102
Annuals > 3 > income Statement > dividends Per Share
39250000
Annuals > 3 > income Statement > shares Outstanding
31400000
Annuals > 3 > income Statement > income Tax Expense
40624000
Annuals > 3 > income Statement > EBITDA
293926000
Annuals > 3 > income Statement > operating Margin
11.937994949289289
Annuals > 3 > income Statement > total Other Income Expense Net
-
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
114051000
Annuals > 3 > balance Sheet > short Term Investments
19729000
Annuals > 3 > balance Sheet > receivables
212385000
Annuals > 3 > balance Sheet > inventories
238270000
Annuals > 3 > balance Sheet > total Current Assets
657181000
Annuals > 3 > balance Sheet > property Plant Equipment
904324000
Annuals > 3 > balance Sheet > total Assets
2877468000
Annuals > 3 > balance Sheet > payables
284253000
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
655000000
Annuals > 3 > balance Sheet > total Liabilities
1875263000
Annuals > 3 > balance Sheet > equity
981321000
Annuals > 3 > balance Sheet > currency_symbol
EUR
Annuals > 3 > cash Flow > net Income
83788000
Annuals > 3 > cash Flow > depreciation
142462000
Annuals > 3 > cash Flow > change In Working Capital
-3860000
Annuals > 3 > cash Flow > cash From Operations
212076000
Annuals > 3 > cash Flow > capital Expenditures
206481000
Annuals > 3 > cash Flow > cash From Investing
-197036000
Annuals > 3 > cash Flow > cash From Financing
8025000
Annuals > 3 > cash Flow > net Change In Cash
25193000
Annuals > 3 > cash Flow > currency_symbol
EUR
Annuals > 3 > ratios > PE
2.668407643312102
Annuals > 3 > ratios > PB
0.24886199317043048
Annuals > 3 > ratios > ROE
8.53828665645594
Annuals > 3 > ratios > ROA
2.911865570703132
Annuals > 3 > ratios > FCF
5595000
Annuals > 3 > ratios > Piotroski FScore
3
Annuals > 3 > ratios > fcf Percent
0.0037349625202018413
Annuals > 3 > health Score
47
Valuation > metrics > PE
38.8875
Valuation > metrics > PB
0.18655029503205875
Valuation > final Score
53.334999999999994
Valuation > verdict
12.9% Undervalued
Profitability > metrics > ROE
1.182142105661546
Profitability > metrics > ROA
1.4964630095055247
Profitability > metrics > Net Margin
0.028340728038557906
Profitability > final Score
11
Profitability > verdict
Weak
Risk > metrics > Debt Equity
2.2842599337644867
Risk > metrics > Interest Coverage
2.1490435594011115
Risk > final Score
27
Risk > verdict
High
Liquidity > metrics > Current Ratio
3.6161226027331943
Liquidity > metrics > Quick Ratio
2.01163149244859
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
90
Prev Valuations > 2
90
Prev Profitabilities > 0
0
Prev Profitabilities > 1
26
Prev Profitabilities > 2
21
Prev Risks > 0
19
Prev Risks > 1
52
Prev Risks > 2
43
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T21:55:57.264Z
Earnings History > 0 > period
2025-08-31
Earnings History > 0 > report Date
2025-08-31
Earnings History > 0 > date
2025-08-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.1068
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-05-31
Earnings History > 1 > report Date
2025-07-09
Earnings History > 1 > date
2025-05-31
Earnings History > 1 > before After Market
BeforeMarket
Earnings History > 1 > currency
EUR
Earnings History > 1 > eps Actual
0.1368
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-02-28
Earnings History > 2 > report Date
2025-04-09
Earnings History > 2 > date
2025-02-28
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
EUR
Earnings History > 2 > eps Actual
-0.1358
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2024-11-30
Earnings History > 3 > report Date
2025-02-20
Earnings History > 3 > date
2024-11-30
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
EUR
Earnings History > 3 > eps Actual
0.2915
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2024-08-31
Earnings History > 4 > report Date
2024-10-10
Earnings History > 4 > date
2024-08-31
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
EUR
Earnings History > 4 > eps Actual
0.2142
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2024-05-31
Earnings History > 5 > report Date
2024-07-11
Earnings History > 5 > date
2024-05-31
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
EUR
Earnings History > 5 > eps Actual
0.2538
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2024-02-29
Earnings History > 6 > report Date
2024-04-11
Earnings History > 6 > date
2024-02-29
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
EUR
Earnings History > 6 > eps Actual
0.1023
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2023-11-30
Earnings History > 7 > report Date
2024-02-22
Earnings History > 7 > date
2023-11-30
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
EUR
Earnings History > 7 > eps Actual
0.3218
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2023-08-31
Earnings History > 8 > report Date
2023-08-31
Earnings History > 8 > date
2023-08-31
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
EUR
Earnings History > 8 > eps Actual
0.2218
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2023-05-31
Earnings History > 9 > report Date
2023-05-31
Earnings History > 9 > date
2023-05-31
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
EUR
Earnings History > 9 > eps Actual
0.2841
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2023-02-28
Earnings History > 10 > report Date
2023-02-28
Earnings History > 10 > date
2023-02-28
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
EUR
Earnings History > 10 > eps Actual
0.1025
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Gerresheimer AG, together with its subsidiaries, provides medicine packaging, drug delivery devices, and solutions in Germany and internationally. The company operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. It offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and containers, bottles, caps, closures, applicators, and accessories; development, industrialization and contract manufacturing of drug delivery programs; project and quality management; and drug delivery devices, including inhalers, injection/auto injectors, and pen injectors. The company also provides diagnostic and medical devices comprising point-of-care tests, laboratory disposables, chemical and technical bottles, diagnostic and polymer vials, dropper bottles, PET bottles, and medical products comprising lancing devices, infusion sets, and disposable systems. In addition, it offers cosmetic packaging solutions, such as moulded glass flacons and jars; tubular glass ampoules, droppers, samplers and vials; and plastic packaging products, as well as pharmaceutical, laboratory, and regulatory affairs services. The company offers its products to pharmacy chains, supermarkets, and wholesalers. It serves pharma, biotech, medical technology, diagnostics, cosmetics, glass containers, and food and beverage industries. Gerresheimer AG was founded in 1864 and is based in Düsseldorf, Germany.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AGerresheimer: Strong Growth Projections Make Stock Look Cheap (OTCMKTS:GRRMF) - Seeking Alpha
5/29/2025
Gerresheimer: Strong Growth Projections Make Stock Look Cheap (OTCMKTS:GRRMF) Seeking Alpha
Read more →(Last Updated 2025-05-31)
Health Score
Price to Earnings Ratio (P/E)
-
Low
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Medium
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Gerresheimer AG
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-08-31
EPS Actual
-0.1068
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-05-31)
(Last Updated 2025-05-31)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-05-31)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-05-31)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.